摘要
目的探讨纤维蛋白原与D-二聚体在急性脑梗死(ACI)病情判断中的临床意义。方法选择80例因ACI入我院住院治疗的患者为观察组,于治疗前和治疗第3、7、14天取血检测纤维蛋白原与D-二聚体水平;以40名社区健康老年人为正常对照组。于治疗前和治疗第3、7、14天取血检测纤维蛋白原与D-二聚体水平。结果正常对照组纤维蛋白原水平为(3.5±1.0)g/L,D-二聚体(0.4±0.1)g/L,观察组治疗前,治疗第3、7、14天纤维蛋白原和D-二聚体分别为(12.7±3.2)g/L,(1.8±0.3)g/L;(9.6±5.0)g/L,(1.4±0.7)g/L;(6.6±3.4)g/L,(0.9±0.3)g/L;(3.7±1.0)g/L,(0.6±0,4)g/L。观察组治疗前与治疗第3、7天二指标水平均明显高于对照组(P〈0.05);治疗第3、7、14天二指标水平均明显低于治疗前(均P〈0.05)。结论纤维蛋白原与D-二聚体水平检测对患者的病情评估具有一定的临床价值。
Objective To observe the changes of fibrinogen and D-dimer in acute cerebral infarction (ACI) patients before and after treatment, and to investigate the clinical significance. Metbods Eighty patients of ACI were chosen as the observation group; 40 patients of community healthy elderly were chosen as the control group. All patients had blood test of fibrinogen and D-dimer before treatment, 3, 7, 14 days after treatment. The results were eomparated and analyzed. Results The levels of fibfinogen and D- two dimer in normal control group were(3.5 ±1 ) g/L, (0.4 ± 0.1) g/L respectively; those in the observation group before treatment, 3,7, 14 days after treatment were (12.7 ±3.2)g/L, (1.8 ±0.3)g/L; (9.6±5)g/L, (1.4 ±0.7)g/L; (6.6 ±3.4)g/L, (0.9 ± 0.3) g/L; (3.7 ±1 ) g/L, (0.6 ± 0.4) g/L respectively. The index in the observation group before treatment and after treatment all increased compared with control group ( P 〈 0. 05 ) ; compared with before treatment, fibrinogen and D- dimer in the observation group 3, 7, 14 days after treatment decreased (all P 〈 0. 05 ). Conclusion Fibrinogen and D-dimer have close ties with ACI.
出处
《中国医药》
2013年第1期31-32,共2页
China Medicine